Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer

Pancreatic Adenocarcinoma, Version 2.2014

(2017) Margaret A. Tempero et al.   Journal of the National Comprehensive Cancer Network

Cell-free DNA as a novel marker in cancer therapy

(2015) Shumei Kato et al.   Biomarkers in Medicine

Detection ofK-rasgene mutation by liquid biopsy in patients with pancreatic cancer

(2015) Hideaki Kinugasa et al.   CANCER

Unique features of mutations revealed by sequentially reprogrammed induced pluripotent stem cells

(2015) Shuai Gao et al.   Nature Communications

Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

(2015) Mark Sausen et al.   Nature Communications

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer

(2015) Erina Takai et al.   Scientific Reports

Liquid Biopsies: Genotyping Circulating Tumor DNA

(2014) Luis A. Diaz et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection

(2014) Kyongchol Kim et al.   Annals of Surgical Treatment and Research

The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC

(2013) A D Nygaard et al.   BRITISH JOURNAL OF CANCER

Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions

(2013) Andrew D. Rhim et al.   GASTROENTEROLOGY

KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer

(2013) Stefan Boeck et al.   JOURNAL OF GASTROENTEROLOGY

Absolute quantification by droplet digital PCR versus analog real-time PCR

(2013) Christopher M Hindson et al.   NATURE METHODS

Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

(2013) Sarah-Jane Dawson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening for Pancreatic Cancer

(2012) Katherine E. Poruk et al.   ANNALS OF SURGERY

Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer

(2012) D. Hashad et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer

(2012) Takeshi Ogura et al.   JOURNAL OF GASTROENTEROLOGY

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

(2012) Andrew V. Biankin et al.   NATURE

High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number

(2011) Benjamin J. Hindson et al.   ANALYTICAL CHEMISTRY

Circulating tumour markers can define patients with normal colons, benign polyps and cancers

(2011) R Mead et al.   BRITISH JOURNAL OF CANCER

Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer

(2011) Leticia De Mattos-Arruda et al.   Future Oncology

Plasma cell-free DNA in ovarian cancer

(2010) Aparna A. Kamat et al.   CANCER

K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer

(2010) H. Chen et al.   EJSO

Coordinated Epidermal Growth Factor Receptor Pathway Gene Overexpression Predicts Epidermal Growth Factor Receptor Inhibitor Sensitivity in Pancreatic Cancer

(2008) A. Jimeno et al.   CANCER RESEARCH

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE